Bronovo Hospital
The Hague, South Holland, 2597 AX, Netherlands
NCT Number: NCT00250237
In this study the investigators want to determine if treatment with haloperidol direct post-operatively after acute hip surgery in high risk patients protects against developing a post-operative delirium.
Looking for future studies?
Notify Me75 year and older
All sexes
Interventional
Phase 3
The Hague, South Holland, 2597 AX, Netherlands
A post-operative delirium is a serious and frequent (35-65%) complication with high morbidity and mortality in high risk patients. In this study we investigate whether we can prevent a delirium from occuring after surgery in patients with a hip fracture of 75 years of age and older. It's a randomised double-blind single centre placebo-controlled study of haloperidol versus placebo.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Haloperidol 1mg twice daily during 72hours
Placebo 1mg twice daily during 72hours
Time frame: 72 hours post surgery
Time frame: days
Time frame: during hospitalization
Bronovo Hospital
Other
Randomised Double-blind Placebo-controlled Study of Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06028126
Anesthesia, Local, Chemically-Induced Disorders
Calgary, Alberta, Canada
View Trial DetailsNCT03785158
Confusion, Delirium
Hamilton, Ontario, Canada
View Trial DetailsNCT05159648
Confusion, Delirium
Rochester, Minnesota, United States
View Trial DetailsNCT06748391
Confusion, Delirium
Wuhan, Hubei, China
View Trial Details